Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Invitation to KOL talk at a national conference
-
My client will be attending a national conference. There will be KOLs presenting studies about the product's efficacy as well as a head-to-head study as part of a symposium. The talks are 3rd party at arm's length. Would this be PAAB exempt?
-
Hey @natbourre
This would be an opinion for exemption. We suggest submitting with additional details around the therapeutic area, talks, sponsorship, influence over content, relationship with the speaker, etc. in order for PAAB to make an assessment.
